Great post @afrowest - I think I can comment on a few of those issues.
Sales is a lot about advertising, exposure and availability. We have just massively increased all three of those things - the CES exposure has been HUGE - have you seen the spikes in Twitter and Facebook likes for Nuheara? Monstrous.
The market out there is gigantic, so I think that sales will trend upwards now at a high rate and in that there will be room to sell 3 products. It wont be past sales divided by 3. It will be 5 or 10 times past sales divided by 3.
Boost is $500 US - compared to $299US for IQbuds.
The three products will go exactly where they are supposed to:
IQbuds to the 40 - 60 age group with impaired hearing - where they have gone so far.
IQ Boost will go via Audiologist and Chemists to those 50 - 80 with poor hearing who cant afford $5 - $10,000 hearing aids.
LiveIQ will sell to those who wouldn't pay a lot more than Apple Airpods - coz they didn't need the hearing assist. But wil lnow buy a better product with a better look for a similar price.
Three substantially different markets - probably doubling our market base spread than just the IQbuds base.
Wilson microchip fund sold on a 15% STOP/LOSS caused by the sell out by no 3 holder S Coupe post the 9.2c raising. That's it. No more to it. If they bought in at 9.2c they must have thought it was good value. So what value is 7.6c now when Nuheara has grown so much?? Will Wilson come back? I have no idea. But there is no doubt NUH is a better buy now at 7.6c than it was then at 9.2c.
Hope that helps. Your post was well informed and raised sound issues. Happy to answer more if you have more.
NUH Price at posting:
7.8¢ Sentiment: Buy Disclosure: Held
(20min delay)